EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Immune Microenvironment in Liver Cancer: From Analysis to Targeting

Jiaming Lan, Hao Li, Jian Xue, Yourong Duan, Jin Sun, Meng Niu iD

Advanced Science · 2025

DOI: 10.1002/advs.202518487 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Science, 2025. Verfasst von Jiaming Lan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Liver Neoplasms, Immunotherapy, Nanomedicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 548 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite advancements in early detection and treatment, liver cancer (LC) remains highly recurrent due to its complex immunosuppressive tumor microenvironment (TME), leading to poor prognosis in advanced stages. Nanomedicines (NMs) offer novel therapeutic strategies for reversing the immunosuppressive TME in LC. This review systematically analysed the diverse mechanisms contributing to immunosuppressive TME formation and explored the potential of smart responsive NMs in targeted drug delivery, immune remodeling, and multimodal therapy. The immunosuppressive TME in LC arises from abnormal physiological conditions, extracellular matrix (ECM) deposition, dysfunction of antigen‐presenting cells, exhaustion of T cells, infiltration of immunosuppressive cells, metabolic reprogramming, and microbiota influences. Smart NMs can overcome delivery barriers through passive targeting and ligand‐directed active targeting to LC cells via receptors, as well as to immunosuppressive cell populations. NMs can respond to endogenous and exogenous stimuli, enabling precise spatiotemporal drug release. This feature enables integration of chemotherapy, immunotherapy, and physical therapies. Additionally, NMs can reprogram the TME by remodeling physiological conditions, inhibiting ECM deposition, regulating metabolism, inducing immunogenic cell death, and modulating microbiota‐derived metabolites. Although toxicity and clinical translation still require further optimization, smart NMs offer a paradigm shift for LC therapy through an integrated “targeted delivery‐immune reprogramming” strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentLiver NeoplasmsImmunotherapyNanomedicineAntineoplastic AgentsHumansDrug Delivery SystemsAnimalsImmune Tolerance

Stichwörter der Autor:innen

immune reprogrammingliver cancernanomedicinestargeted deliverytumor microenvironment

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Interventional Radiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China.
  • China Medical University, Shenyang, Liaoning, 110122, China.
  • State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200032, China.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China.
  • Joint International Research Laboratory of Intelligent Drug Delivery Systems, Ministry of Education , Shenyang, Liaoning, 110016, China.

ORCID-Profile: Meng Niu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Liaoning Province

Zitieren

APA

Lan, J., Li, H., Xue, J., Duan, Y., Sun, J., & Niu, M. (2025). The Immune Microenvironment in Liver Cancer: From Analysis to Targeting. Advanced Science. https://doi.org/10.1002/advs.202518487

Vancouver

Lan J, Li H, Xue J, Duan Y, Sun J, Niu M. The Immune Microenvironment in Liver Cancer: From Analysis to Targeting. Advanced Science. 2025. doi:10.1002/advs.202518487

BibTeX
@article{Lan2025,
  author = {Lan, Jiaming and Li, Hao and Xue, Jian and Duan, Yourong and Sun, Jin and Niu, Meng},
  title = {The Immune Microenvironment in Liver Cancer: From Analysis to Targeting},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202518487}
}
Kostenlos starten →